December 1 is World AIDS Day. A day to learn about and address persistent disparities related to HIV and AIDS. This year, the World Health Organization partnered with World AIDS Day to highlight the inequalities that constrain ending the HIV pandemic. This World Health Day aims to equalize vital HIV services for the most vulnerable populations and destigmatize HIV/AIDS through education. According to UNAIDS, in 2021 there were 38.4 million people globally living with HIV and 1.5 million people were newly infected. GlobalData’s HIV Tests Market Model indicates that more than 538 million HIV tests were sold globally in 2021 and approximately 540 million will be sold in 2030*. GlobalData predicts that the global HIV testing market will reach $2.3 billion by 2030* at a CAGR of 1.5%.
The Covid-19 pandemic has normalized frequent disease testing. People are becoming more proactive in monitoring their health, particularly in infectious diseases. This testing momentum combined with increased HIV awareness and education will cause people to get tested more frequently. According to GlobalData analysis, the HIV testing market has recovered from the declining market returns observed in 2020 due to the Covid-19 pandemic as many health organizations such as CDC, cut public spending on HIV testing to compensate for Covid-19 testing.
*It does not include multifactorial HIV, hepatitis B, and hepatitis C nucleic acid amplification tests.